William A. Nahhas - Concepedia

Concepedia

Author

William A. Nahhas

Penn State Milton S. Hershey Medical Center

Also Known As

W A Nahhas, W Nahhas, W. A. NAHHAS, W. A. Nahhas, W. Nahhas, W.A. NAHHAS, W.A. Nahhas, WILLIAM A. NAHHAS, William A. Nahhas, William Nahhas

62

Publications

1.5K

Citations

20

H-Index

54

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center Wright State University Pennsylvania State University Miami Valley Hospital University of Arizona Cancer Center

WA

About

William A. Nahhas is an author at Penn State Milton S. Hershey Medical Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	30	1K
2	Public Health	4	4	322
3	Health Sciences	2	2	44
4	Engineering	1	1	11
5	Social Sciences	1	1	19

William A. Nahhas

×

35

Publications

1.5K

Citations

19

H-Index

	Year	Citations
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. David S. Alberts, S Green, Edward V. Hannigan, Journal of Clinical Oncology	1992	299
Analysis of factors contributing to treatment failures in Stages IB and IIA carcinoma of the cervix C.K. Chung, William A. Nahhas, John A. Stryker, American Journal of Obstetrics and Gynecology Cervical Cancer ManagementCervical CancerMedicineCancer ManagementTreatment Failures	1980	196
The preservation of ovarian function in young women undergoing pelvic radiation therapy Nader Husseinzadeh, William A. Nahhas, Donald E. Velkley, Gynecologic Oncology Hormonal ContraceptiveFertilityPelvic Radiation TherapyGynecologyFemale Reproductive System	1984	93
A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients Howard D. Homesley, Don Hall, George Lewandowski, Gynecologic Oncology MedicineDose-escalating StudyMetronomic TherapyGynecologyWeekly Bolus Topotecan	2001	82
Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities. David R. Gandara, William A. Nahhas, Mark Adelson, Journal of Clinical Oncology	1995	70
Carcinoma of the Corpus Uteri William A. Nahhas, Curtis J. Lund, Jerome H. Rudolph Obstetrics and Gynecology PathologyGynecologyEndometrial CarcinomaGynecology OncologyCarcinoma	1971	66
Epithelial Alterations in Proximity to Invasive Squamous Carcinoma of the Vulva Richard J. Zaino, Nader Husseinzadeh, William A. Nahhas, International Journal of Gynecological Pathology GynecologyPathologyCarcinomaEpithelial AlterationsCancer-associated Virus	1982	63
Second-look laparotomy for ovarian cancer Stephen Curry, M M Zembo, William A. Nahhas, Gynecologic Oncology Gynecologic SurgeryLaparoscopySurgical OncologyGynecological SurgeryMedicine	1981	58
Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix C.K. Chung, William A. Nahhas, Richard J. Zaino, Gynecologic Oncology Tumoral PathologyCervical CancerSquamous Cell CarcinomaMedicineSurgical Pathology	1981	44
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma Levi S. Downs, Patricia L. Judson, Peter A. Argenta, Cancer	2007	36

Page 1